Mild progressive multifocal leukoencephalopathy after switching from natalizumab to ocrelizumab

OBJECTIVE: To describe the disease course of carryover progressive multifocal leukoencephalopathy (PML) after switching from natalizumab to ocrelizumab in 2 patients with relapsing-remitting MS. METHODS: Two case reports with 1 year of follow-up and retrospective longitudinal measurements of serum n...

Descripción completa

Detalles Bibliográficos
Autores principales: Toorop, Alyssa A., van Lierop, Zoë Y.G., Strijbis, Eva E.M., Teunissen, Charlotte E., Petzold, Axel, Wattjes, Mike P., Barkhof, Frederik, de Jong, Brigit A., van Kempen, Zoé L.E., Killestein, Joep
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7577542/
https://www.ncbi.nlm.nih.gov/pubmed/33051344
http://dx.doi.org/10.1212/NXI.0000000000000904

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7577542/
https://www.ncbi.nlm.nih.gov/pubmed/33051344
http://dx.doi.org/10.1212/NXI.0000000000000904

Ejemplares similares